Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
PIII
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-4.50
vs -0.25
Q3.23
N/A
-6.00
vs -0.27
Q4.23
N/A
-11.00
vs -112454.50
Q1.24
N/A
-8.00
vs -11.00
Q2.24
N/A
-7.50
vs -4.50
Q3.24
N/A
-15.50
vs -6.00
Q4.24
N/A
-16.00
vs -11.00
Q1.25
N/A
-6.28
vs -8.00
Q2.25
N/A
-5.85
vs -7.50
Q3.25
N/A
-4.04
vs -15.50
Sales Growth
YoY
Current
Estimates
Q2.23
+22%
329.1M vs 269.5M
Q3.23
+16%
288.4M vs 248.3M
Q4.23
+34%
346.9M vs 258.2M
Q1.24
+29%
388.5M vs 302.1M
Q2.24
+15%
379.2M vs 329.1M
Q3.24
+26%
362.1M vs 288.4M
Q4.24
+7%
370.7M vs 346.9M
Q1.25
-4%
373.2M vs 388.5M
Q2.25
-6%
358.2M vs 379.2M
Q3.25
-4%
347.2M vs 362.1M
Return on Equity
QoQ
Q2.23
+7%
0.07
vs 3.43
Q3.23
-7%
-0.07
vs 0.07
Q4.23
-18%
-0.18
vs -0.07
Q1.24
-13%
-0.13
vs -0.18
Q2.24
-7%
-0.07
vs -0.13
Q3.24
-39%
-0.39
vs -0.07
Q4.24
-77%
-0.77
vs -0.39
Q1.25
-32%
-0.32
vs -0.77
Institutionnal Ownership
QoQ
Q2.23
65
65
vs 47
38%
Q3.23
67
67
vs 65
3%
Q4.23
67
67
vs 67
NA
Q1.24
63
63
vs 67
-6%
Q2.24
58
58
vs 63
-8%
Q3.24
46
46
vs 58
-21%
Q4.24
39
39
vs 46
-15%
Q1.25
33
33
vs 39
-15%
globenewswire.com
8 hours ago
zacks.com
10 hours ago
globenewswire.com
11 hours ago
globenewswire.com
12 hours ago
globenewswire.com
12 hours ago
Relative Strength
PIII
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
0.12Â ( 1.77%)
Relative Strenght
100
Volume Buzz
-99%
Earning Acce
No
Dist 52w H.
80%Forecast
315%2026-Revenue
-123%2026-EPS
-2801%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
BTIG
downgradePrevious: Not converted
2024-04-01
Now: Neutral